Index
1 Market Overview of Seasonal Influenza Vaccines Therapeutics
1.1 Seasonal Influenza Vaccines Therapeutics Market Overview
1.1.1 Seasonal Influenza Vaccines Therapeutics Product Scope
1.1.2 Seasonal Influenza Vaccines Therapeutics Market Status and Outlook
1.2 Global Seasonal Influenza Vaccines Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Seasonal Influenza Vaccines Therapeutics Market Size by Region (2018-2029)
1.4 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Seasonal Influenza Vaccines Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
1.6.1 North America Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
1.6.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
1.6.4 Latin America Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
2 Seasonal Influenza Vaccines Therapeutics Market by Type
2.1 Introduction
2.1.1 Paediatrics
2.1.2 Adolescence
2.1.3 Adults
2.1.4 Elderly
2.2 Global Seasonal Influenza Vaccines Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Type (2018-2029)
3 Seasonal Influenza Vaccines Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Seasonal Influenza Vaccines Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Seasonal Influenza Vaccines Therapeutics Revenue Breakdown by Application (2018-2029)
4 Seasonal Influenza Vaccines Therapeutics Competition Analysis by Players
4.1 Global Seasonal Influenza Vaccines Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2022)
4.3 Date of Key Players Enter into Seasonal Influenza Vaccines Therapeutics Market
4.4 Global Top Players Seasonal Influenza Vaccines Therapeutics Headquarters and Area Served
4.5 Key Players Seasonal Influenza Vaccines Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Seasonal Influenza Vaccines Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GSK
5.1.1 GSK Profile
5.1.2 GSK Main Business
5.1.3 GSK Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.1.4 GSK Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 GSK Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.2.4 Novartis Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Recent Developments
5.3 CSL
5.3.1 CSL Profile
5.3.2 CSL Main Business
5.3.3 CSL Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.3.4 CSL Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 MedImmune Recent Developments
5.4 MedImmune
5.4.1 MedImmune Profile
5.4.2 MedImmune Main Business
5.4.3 MedImmune Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.4.4 MedImmune Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 MedImmune Recent Developments
5.5 Sanofi-Pasteur
5.5.1 Sanofi-Pasteur Profile
5.5.2 Sanofi-Pasteur Main Business
5.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.5.4 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi-Pasteur Recent Developments
5.6 Solvay
5.6.1 Solvay Profile
5.6.2 Solvay Main Business
5.6.3 Solvay Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.6.4 Solvay Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Solvay Recent Developments
5.7 Hualan Biological Engineering
5.7.1 Hualan Biological Engineering Profile
5.7.2 Hualan Biological Engineering Main Business
5.7.3 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.7.4 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Hualan Biological Engineering Recent Developments
5.8 Sinovac Biotech
5.8.1 Sinovac Biotech Profile
5.8.2 Sinovac Biotech Main Business
5.8.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.8.4 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Sinovac Biotech Recent Developments
5.9 Changchun Institute of Biological Products Co., Ltd.
5.9.1 Changchun Institute of Biological Products Co., Ltd. Profile
5.9.2 Changchun Institute of Biological Products Co., Ltd. Main Business
5.9.3 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.9.4 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Changchun Institute of Biological Products Co., Ltd. Recent Developments
5.10 Shanghai Institute of Biological Products Co., Ltd.
5.10.1 Shanghai Institute of Biological Products Co., Ltd. Profile
5.10.2 Shanghai Institute of Biological Products Co., Ltd. Main Business
5.10.3 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Products, Services and Solutions
5.10.4 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Shanghai Institute of Biological Products Co., Ltd. Recent Developments
6 North America
6.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Seasonal Influenza Vaccines Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Seasonal Influenza Vaccines Therapeutics Market Dynamics
11.1 Seasonal Influenza Vaccines Therapeutics Industry Trends
11.2 Seasonal Influenza Vaccines Therapeutics Market Drivers
11.3 Seasonal Influenza Vaccines Therapeutics Market Challenges
11.4 Seasonal Influenza Vaccines Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List